Table 1 |
|
|
Clinicopathological data for 40 patients with colorectal cancer (tissues: colorectal tumour n = 35 and normal n = 39) |
|
|
Characteristics (n = 40) |
Number (percentage) |
|
|
|
|
Age (mean ± standard deviation) |
66.7 ± 13.1 |
|
|
|
|
Sex |
|
|
Male |
28 (70.0) |
|
Female |
12 (30.0) |
|
|
|
|
Location of tumors |
|
|
Colon |
11 (27.5) |
|
Rectum |
29 (72.5) |
|
|
|
|
Pathologic T classification |
|
|
Tx |
2 (5.0) |
|
Tis |
1 (2.5) |
|
T1 |
4 (10.0) |
|
T2 |
9 (22.5) |
|
T3 |
12 (30.0) |
|
T4 |
11 (27.5) |
|
N/A |
1 (2.5) |
|
|
|
|
Pathologic N classification |
|
|
Nx |
2 (5.0) |
|
N0 |
22 (55.0) |
|
N1 |
11 (27.5) |
|
N2 |
4 (10.0) |
|
N/A |
1 (2.5) |
|
|
|
|
Metastasis classification |
|
|
M0 |
34 (87.5) |
|
M1 |
6 (12.5) |
|
|
|
|
AJCC classification |
|
|
Stage 0 |
1 (2.5) |
|
Stage I |
10 (25.0) |
|
Stage II |
10 (25.0) |
|
Stage III |
11 (27.5) |
|
Stage IV |
6 (12.5) |
|
pCR |
2 (10.0) |
|
|
|
|
Differentiation |
|
|
Well |
1 (2.5) |
|
Moderate |
24 (60.0) |
|
Poor |
8 (20.0) |
|
N/A |
7 (35.0) |
|
|
|
|
AJCC, American Joint Committee on Cancer; pCR, pathologic complete response following neoadjuvant therapy. |
|
|
Chang et al. BMC Cancer 2010 10:173 doi:10.1186/1471-2407-10-173 |
|
